Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 189,600.00 KRW | -2.27% |
|
-3.02% | +9.99% |
| Aug. 25 | Celltrion Launches Omlyclo 300 Mg Strength In Key European Markets | CI |
| Aug. 23 | Celltrion Submits Marketing Application for Keytruda Biosimilar in South Korea | MT |
| Market Cap | 46,416B 33.48B 28.73B 26.97B 24.63B 46.49B 3,193B 46.71B 319B 124B 1,611B 126B 123B 5,335B | P/E 2026 * |
29.4x | P/E 2027 * | 25.5x |
|---|---|---|---|---|---|
| Enterprise Value | 48.61B 35.06M 30.09M 28.25M 25.8M 48.69M 3.34B 48.92M 334M 130M 1.69B 132M 129M 5.59B | EV / Sales 2026 * |
8.87x | EV / Sales 2027 * | 7.6x |
| Free-Float |
60.59% | Yield 2026 * |
0.39% | Yield 2027 * | 0.42% |
| 1 day | -2.27% | ||
| 1 week | -3.02% | ||
| Current month | +1.55% | ||
| 1 month | +6.76% | ||
| 3 months | +0.19% | ||
| 6 months | -18.58% | ||
| Current year | +9.99% |
| 1 week | 187,600 |  | 202,000 |
| 1 month | 175,800 | | 212,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 50 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 500 | 0.0002% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| -0.31% | +0.03% | +2.38% | +23.24% | 50.96B | |
| +1.92% | +0.36% | +477.97% | +550.09% | 46.18B | |
| -0.15% | -0.28% | +21.65% | +89.41% | 42.73B | |
| +0.81% | +4.91% | +39.28% | +19.41% | 43.04B | |
| +0.81% | +1.77% | +31.91% | +138.26% | 17.28B | |
| -1.08% | -3.61% | - | - | 16.43B | |
| -0.38% | -0.44% | +11.26% | +28.00% | 14.73B | |
| -0.85% | +1.76% | +80.26% | +47.26% | 14.09B | |
| +0.01% | -2.06% | -1.65% | -34.09% | 13.03B | |
| Average | -0.04% | +0.99% | +75.25% | +101.45% | 29.2B | |
| Weighted average by Cap. | +0.19% | +1.02% | +98.40% | +130.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,480B 3.95B 3.39B 3.18B 2.91B 5.49B 377B 5.52B 37.68B 14.6B 190B 14.84B 14.52B 630B | 6,294B 4.54B 3.9B 3.66B 3.34B 6.3B 433B 6.33B 43.28B 16.77B 218B 17.04B 16.67B 723B |
| Net income | 1,511B 1.09B 935M 878M 802M 1.51B 104B 1.52B 10.39B 4.03B 52.43B 4.09B 4B 174B | 1,763B 1.27B 1.09B 1.02B 936M 1.77B 121B 1.77B 12.12B 4.7B 61.2B 4.78B 4.67B 203B |
| Net Debt | 2,199B 1.59B 1.36B 1.28B 1.17B 2.2B 151B 2.21B 15.12B 5.86B 76.3B 5.95B 5.82B 253B | 1,409B 1.02B 872M 819M 748M 1.41B 96.93B 1.42B 9.69B 3.75B 48.9B 3.82B 3.73B 162B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-26 | ₩193,400.00 | +2.00% | 326,386 |
| 26-08-25 | ₩189,600.00 | -2.27% | 358,412 |
| 26-08-24 | ₩194,000.00 | +0.88% | 314,860 |
| 26-08-21 | ₩192,300.00 | -0.93% | 354,956 |
| 26-08-20 | ₩194,100.00 | 0.00% | 484,272 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
